Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026)

Alector's (ALEC) quarterly Non-Current Deffered Revenue came in at $162.9 million in Q1 2026, down 4.37% year-on-year from $170.3 million in Q1 2025, and down 1.02% on a QoQ basis from $164.5 million in Q4 2025.

Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Non-Current Deffered Revenue data on file, last reported at $162.9 million in Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 4.37% year-over-year to $162.9 million in Q1 2026; TTM through Mar 2026 was $162.9 million, a 4.37% decrease from a year earlier, with the FY2025 full-year figure at $164.5 million, down 4.43% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $162.9 million, down from $164.5 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for ALEC reached as high as $505.1 million in Q1 2022 and fell as low as $162.9 million in Q1 2026.
  • Historically, Non-Current Deffered Revenue has averaged $262.9 million across 5 years, with a median of $204.6 million in 2024.
  • Across the five-year window, Non-Current Deffered Revenue surged 378.83% in 2022 and plunged 52.54% in 2024, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $443.4 million in 2022, then slumped by 52.44% to $210.8 million in 2023, then slipped by 18.34% to $172.2 million in 2024, then slipped by 4.43% to $164.5 million in 2025, then fell by 1.02% to $162.9 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $162.9 million in Q1 2026, $164.5 million in Q4 2025, and $167.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alector 164.78 Mn -41.74 Mn - 162.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 162.87 Mn
Dec 31, 2025 164.54 Mn
Sep 30, 2025 167.27 Mn
Jun 30, 2025 168.87 Mn
Mar 31, 2025 170.31 Mn
Dec 31, 2024 172.17 Mn
Sep 30, 2024 192.78 Mn
Jun 30, 2024 199.58 Mn
Mar 31, 2024 204.58 Mn
Dec 31, 2023 210.85 Mn
Sep 30, 2023 229.85 Mn
Jun 30, 2023 245.34 Mn
Mar 31, 2023 431.08 Mn
Dec 31, 2022 443.37 Mn
Sep 30, 2022 386.36 Mn
Jun 30, 2022 413.90 Mn
Mar 31, 2022 505.13 Mn
Dec 31, 2021 334.42 Mn
Sep 30, 2021 344.53 Mn
Jun 30, 2021 96.21 Mn